Literature DB >> 9494831

California-La Crosse encephalitis.

J E McJunkin1, R R Khan, T F Tsai.   

Abstract

La Crosse encephalitis, a mosquito-borne viral disease that can be mistaken for herpes simplex encephalitis, is under-recognized in the United States, despite case reports from 28 states and an incidence in endemic areas (20-30/100,000) exceeding that of bacterial meningitis. The disease recurs every summer in endemic foci in the midwestern and mid-Atlantic United States in areas forested with hardwood trees, which provide breeding sites for the treehole-dwelling mosquito vector, Aedes triseriatus. La Crosse encephalitis should be considered in the child presenting with meningoencephalitis in summer and early fall, particularly for children living in (or recent travel to) endemic areas in mid-Atlantic and midwestern states.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9494831     DOI: 10.1016/s0891-5520(05)70410-4

Source DB:  PubMed          Journal:  Infect Dis Clin North Am        ISSN: 0891-5520            Impact factor:   5.982


  15 in total

1.  Interferon antagonist NSs of La Crosse virus triggers a DNA damage response-like degradation of transcribing RNA polymerase II.

Authors:  Paul Verbruggen; Marius Ruf; Gjon Blakqori; Anna K Överby; Martin Heidemann; Dirk Eick; Friedemann Weber
Journal:  J Biol Chem       Date:  2010-11-30       Impact factor: 5.157

2.  Nucleic acid amplification assays for detection of La Crosse virus RNA.

Authors:  Amy J Lambert; Roger S Nasci; Bruce C Cropp; Denise A Martin; Becky C Rose; Brandy J Russell; Robert S Lanciotti
Journal:  J Clin Microbiol       Date:  2005-04       Impact factor: 5.948

3.  La Crosse Virus Field Detection and Vector Competence of Culex Mosquitoes.

Authors:  M Camille Harris; Fan Yang; Dorian M Jackson; Eric J Dotseth; Sally L Paulson; Dana M Hawley
Journal:  Am J Trop Med Hyg       Date:  2015-07-14       Impact factor: 2.345

4.  Polyamine Depletion Inhibits Bunyavirus Infection via Generation of Noninfectious Interfering Virions.

Authors:  Vincent Mastrodomenico; Jeremy J Esin; Marion L Graham; Patrick M Tate; Grant M Hawkins; Zachary J Sandler; David J Rademacher; Thomas M Kicmal; Courtney N Dial; Bryan C Mounce
Journal:  J Virol       Date:  2019-06-28       Impact factor: 5.103

5.  Efficient cDNA-based rescue of La Crosse bunyaviruses expressing or lacking the nonstructural protein NSs.

Authors:  Gjon Blakqori; Friedemann Weber
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

6.  La Crosse virus (LACV) Gc fusion peptide mutants have impaired growth and fusion phenotypes, but remain neurotoxic.

Authors:  Samantha S Soldan; Bradley S Hollidge; Valentina Wagner; Friedemann Weber; Francisco González-Scarano
Journal:  Virology       Date:  2010-05-31       Impact factor: 3.616

7.  The first reported case of California encephalitis in more than 50 years.

Authors:  B F Eldridge; C Glaser; R E Pedrin; R E Chiles
Journal:  Emerg Infect Dis       Date:  2001 May-Jun       Impact factor: 6.883

8.  La Crosse bunyavirus nonstructural protein NSs serves to suppress the type I interferon system of mammalian hosts.

Authors:  Gjon Blakqori; Sophie Delhaye; Matthias Habjan; Carol D Blair; Irma Sánchez-Vargas; Ken E Olson; Ghassem Attarzadeh-Yazdi; Rennos Fragkoudis; Alain Kohl; Ulrich Kalinke; Siegfried Weiss; Thomas Michiels; Peter Staeheli; Friedemann Weber
Journal:  J Virol       Date:  2007-03-07       Impact factor: 5.103

9.  A duplex real-time reverse transcriptase polymerase chain reaction assay for the detection of California serogroup and Cache Valley viruses.

Authors:  Heng Wang; Seela Nattanmai; Laura D Kramer; Kristen A Bernard; Norma P Tavakoli
Journal:  Diagn Microbiol Infect Dis       Date:  2009-10       Impact factor: 2.803

10.  The incidence risk, clustering, and clinical presentation of La Crosse virus infections in the eastern United States, 2003-2007.

Authors:  Andrew D Haddow; Agricola Odoi
Journal:  PLoS One       Date:  2009-07-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.